Potassium Chloride in Lactated Ringers and Dextrose (Hospira, Inc.)
Welcome to the PulseAid listing for the Potassium Chloride in Lactated Ringers and Dextrose drug offered from Hospira, Inc.. This Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, and DEXTROSE MONOHYDRATE |
| SUBSTANCE NAME: | POTASSIUM CHLORIDE; SODIUM CHLORIDE; CALCIUM CHLORIDE; SODIUM LACTATE; DEXTROSE MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1988-10-17 |
| END MARKETING DATE: | 0000-00-00 |
Potassium Chloride in Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG Details:
| Item Description | Potassium Chloride in Lactated Ringers and Dextrose from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.79; 6; .2; 3.1; 50(g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL) |
| START MARKETING DATE: | 1988-10-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-7111_693e1e2d-8a3c-4983-8e21-80a490935d94 |
| PRODUCT NDC: | 0409-7111 |
| APPLICATION NUMBER: | NDA019685 |
Other POTASSIUM CHLORIDE; SODIUM CHLORIDE; CALCIUM CHLORIDE; SODIUM LACTATE; DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
